Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Moise

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Obstetrics and Gynecology|November 23, 2013
Costs and clinical outcomes of noninvasive fetal RhD typing for targeted prophylaxisKenneth J Moise
The New England Journal of Medicine|July 14, 2006
Diagnosing hemolytic disease of the fetus--time to put the needles away?Kenneth J Moise
Obstetrics and Gynecology|February 7, 2014
William W. Pollack, PhD: a pioneer in perinatologyKenneth J Moise
American Journal of Perinatology|February 27, 2014
The history of fetal therapyKenneth J Moise
American Journal of Obstetrics and Gynecology|August 17, 2024
The use of free DNA for fetal RHD genotyping in the Rh negative pregnant patient-the time has comeKenneth J Moise
Best Practice & Research. Clinical Obstetrics & Gynaecology|April 3, 2025
Considerations and approaches for early onset fetal anemia due to red cell alloimmunizationKenneth J Moise
British Journal of Haematology|September 21, 2022
Immunomodulation for early-onset haemolytic disease of the fetus/newborn: Can we delay the need for intrauterine transfusions?Kenneth J Moise
Obstetrics and Gynecology|December 2, 2005
Umbilical cord stem cellsKenneth J Moise
American Journal of Obstetrics and Gynecology|October 2, 2003
Maternal-fetal surgery for spina bifida: on the brink of a new era?Kenneth J Moise
Obstetrics and Gynecology|September 11, 2002
Management of rhesus alloimmunization in pregnancyKenneth J Moise
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Obstetrics and Gynecology|November 23, 2013
Costs and clinical outcomes of noninvasive fetal RhD typing for targeted prophylaxisKenneth J Moise
The New England Journal of Medicine|July 14, 2006
Diagnosing hemolytic disease of the fetus--time to put the needles away?Kenneth J Moise
Obstetrics and Gynecology|February 7, 2014
William W. Pollack, PhD: a pioneer in perinatologyKenneth J Moise
American Journal of Perinatology|February 27, 2014
The history of fetal therapyKenneth J Moise
American Journal of Obstetrics and Gynecology|August 17, 2024
The use of free DNA for fetal RHD genotyping in the Rh negative pregnant patient-the time has comeKenneth J Moise
Best Practice & Research. Clinical Obstetrics & Gynaecology|April 3, 2025
Considerations and approaches for early onset fetal anemia due to red cell alloimmunizationKenneth J Moise
British Journal of Haematology|September 21, 2022
Immunomodulation for early-onset haemolytic disease of the fetus/newborn: Can we delay the need for intrauterine transfusions?Kenneth J Moise
Obstetrics and Gynecology|December 2, 2005
Umbilical cord stem cellsKenneth J Moise
American Journal of Obstetrics and Gynecology|October 2, 2003
Maternal-fetal surgery for spina bifida: on the brink of a new era?Kenneth J Moise
Obstetrics and Gynecology|September 11, 2002
Management of rhesus alloimmunization in pregnancyKenneth J Moise
Pageof 15